The SUNFISH trial will not be conducted in the UK
TreatSMA has learned that UK will not take part in the SUNFISH trial
TreatSMA has learned that UK will not take part in the SUNFISH trial
TreatSMA has learned that UK will not take part in the SUNFISH trial
Recruitment for the SUNFISH clinical trial is about to be completed globally. As of last week, enrollment of participants aged 6–11 and 18–25 years has been completed. But the UK red tape has blocked the sites from opening on time.
Recruitment for the SUNFISH clinical trial is about to be completed globally. As of last week, enrollment of participants aged 6–11 and 18–25 years has been completed. But the UK red tape has blocked the sites from opening on time.
NICE Appraisal Committee will meet on 27 June to discuss draft recommendation for Spinraza provision in England and Wales. You are welcome join!
NICE Appraisal Committee will meet on 27 June to discuss draft recommendation for Spinraza provision in England and Wales. You are welcome join!
Roche stops the development of olesoxime, a neuroprotective drug that showed benefit in spinal muscular atrophy.
Roche stops the development of olesoxime, a neuroprotective drug that showed benefit in spinal muscular atrophy.